In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral- experienced patient who experienced early failure to raltegravir.
ASJC Scopus subject areas
- Microbiology (medical)
- Immunology and Microbiology(all)
- Infectious Diseases